Chaim  Indig net worth and biography

Chaim Indig Biography and Net Worth

CEO of Phreesia
Since co-founding Phreesia in 2005, Chaim Indig has helped revolutionize the patient intake experience. Under his leadership, Phreesia has established a broad national footprint, developed strategic partnerships with some of the world’s largest healthcare companies, and earned accolades for its role in making healthcare more efficient and patient-centered.

Prior to founding Phreesia, he held key roles at Spotfire and OLAP@Work. Chaim is also a recognized business leader, trusted industry expert and sought-after speaker. He was a finalist for Ernst & Young’s “Entrepreneur of the Year” Award and was featured in the Stanford Social Innovation Review as a healthcare innovator.

What is Chaim Indig's net worth?

The estimated net worth of Chaim Indig is at least $30.71 million as of October 15th, 2024. Mr. Indig owns 1,220,647 shares of Phreesia stock worth more than $30,711,479 as of December 22nd. This net worth evaluation does not reflect any other investments that Mr. Indig may own. Additionally, Mr. Indig receives a salary of $515,000.00 as CEO at Phreesia. Learn More about Chaim Indig's net worth.

How old is Chaim Indig?

Mr. Indig is currently 45 years old. There are 5 older executives and no younger executives at Phreesia. The oldest executive at Phreesia is Ms. Janet M. Gunzburg, VP, Principal Accounting Officer & Controller, who is 58 years old. Learn More on Chaim Indig's age.

What is Chaim Indig's salary?

As the CEO of Phreesia, Inc., Mr. Indig earns $515,000.00 per year. The highest earning executive at Phreesia is Mr. David Linetsky, Senior Vice President of Life Sciences, who commands a salary of $551,640.00 per year. Learn More on Chaim Indig's salary.

How do I contact Chaim Indig?

The corporate mailing address for Mr. Indig and other Phreesia executives is 432 Park Avenue South 12th Floor, New York NY, 10016. Phreesia can also be reached via phone at (888) 654-7473 and via email at [email protected]. Learn More on Chaim Indig's contact information.

Has Chaim Indig been buying or selling shares of Phreesia?

Within the last three months, Chaim Indig has sold $64,961.67 in shares of Phreesia stock. Most recently, Chaim Indig sold 3,089 shares of the business's stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $21.03, for a transaction totalling $64,961.67. Following the completion of the sale, the chief executive officer now directly owns 1,220,647 shares of the company's stock, valued at $25,670,206.41. Learn More on Chaim Indig's trading history.

Who are Phreesia's active insiders?

Phreesia's insider roster includes Edward Cahill (Director), Allison Hoffman (General Counsel), Chaim Indig (CEO), David Linetsky (SVP), Gillian Munson (Director), Randy Rasmussen (CFO), Evan Roberts (COO), Amy Vanduyn (SVP), and Michael Weintraub (Director). Learn More on Phreesia's active insiders.

Are insiders buying or selling shares of Phreesia?

In the last twelve months, insiders at the sold shares 62 times. They sold a total of 229,065 shares worth more than $5,314,510.63. The most recent insider tranaction occured on December, 18th when General Counsel Allison C Hoffman sold 3,495 shares worth more than $86,955.60. Insiders at Phreesia own 5.8% of the company. Learn More about insider trades at Phreesia.

Information on this page was last updated on 12/18/2024.

Chaim Indig Insider Trading History at Phreesia

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/15/2024Sell3,089$21.03$64,961.671,220,647View SEC Filing Icon  
9/10/2024Sell5,295$23.25$123,108.751,223,736View SEC Filing Icon  
7/29/2024Sell7$24.75$173.251,219,361View SEC Filing Icon  
7/16/2024Sell2,644$23.74$62,768.561,219,361View SEC Filing Icon  
4/15/2024Sell3,392$22.86$77,541.121,222,005View SEC Filing Icon  
4/8/2024Sell12,043$22.62$272,412.661,225,397View SEC Filing Icon  
1/16/2024Sell3,586$24.55$88,036.301,280,410View SEC Filing Icon  
10/16/2023Sell3,295$16.61$54,729.951,241,996View SEC Filing Icon  
9/13/2023Sell6,555$20.34$133,328.701,245,291View SEC Filing Icon  
8/30/2021Sell54,672$71.35$3,900,847.20View SEC Filing Icon  
8/27/2021Sell57,556$72.29$4,160,723.24View SEC Filing Icon  
8/25/2021Sell600$70.03$42,018.00View SEC Filing Icon  
8/6/2021Sell1,660$70.53$117,079.80View SEC Filing Icon  
7/30/2021Sell102$70.00$7,140.00View SEC Filing Icon  
1/19/2021Sell59,986$63.95$3,836,104.70View SEC Filing Icon  
1/15/2021Sell75,122$62.81$4,718,412.82View SEC Filing Icon  
2/6/2020Sell80,000$33.11$2,648,800.00View SEC Filing Icon  
See Full Table

Chaim Indig Buying and Selling Activity at Phreesia

This chart shows Chaim Indig's buying and selling at Phreesia by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Phreesia Company Overview

Phreesia logo
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
Read More

Today's Range

Now: $25.16
Low: $23.18
High: $25.63

50 Day Range

MA: $20.81
Low: $18.04
High: $25.66

2 Week Range

Now: $25.16
Low: $17.07
High: $29.16

Volume

749,260 shs

Average Volume

452,361 shs

Market Capitalization

$1.46 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.98